Cannabics Pharmaceuticals Inc. Stock Price - CNBX

Best deals to access real time data!
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type ISIN Company Description
Cannabics Pharmaceuticals Inc. (QB) CNBX Other OTC Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  -0.0375 -4.95% 0.72 0.77 0.71 0.755 0.7575 16:00:05
Bid Price Ask Price Spread Spread % News
0.715 0.73 0.015 2.05% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
147 217,097 $ 0.7401 $ 160.68k 264.82k 0.17 - 7.60
Last Trade Time Type Quantity Stock Price Currency
15:55:15 400 $0.72 USD

Cannabics Pharmaceuticals Inc. (QB) Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 86.09M 119.56M $ -307.18k - -280.25 21.94M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Cannabics Pharmaceuticals Inc. (QB) News

Latest CNBX Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical CNBX Price Data

Period † Open High Low VWAP Min Vol Max Vol Avg. Daily Vol [m] Change %
1 Week0.80250.860.710.798679k302k158k-0.0825-10.28%
1 Month0.9151.050.710.866553k763k229k-0.195-21.31%
3 Months1.261.440.711.004246k763k232k-0.54-42.86%
6 Months2.1952.250.67251.154046k2M388k-1.475-67.20%
1 Year0.229957.60.172.029646k11M708k0.49005213.11%
3 Years0.337.60.0211.8040011M268k0.39118.18%
5 Years0.077.60.0211.7983011M223k0.65928.57%

Cannabics Pharmaceuticals Inc. (QB) Description

Cannabics Pharmaceuticals Inc. (CNBX), a U.S based public company, is dedicated to the development of Personalized Anti-Cancer treatments. The Company's scientific focus is on harnessing the proven therapeutic properties of natural Cannabinoids. Cannabics is now creating tailored therapies for cancer patients, utilizing advanced Liquid Biopsy and HTS technology along with personalized bioinformatics tools. The Company's R&D is based in Israel, where it is fully licensed by the Ministry of Health and involves both scientific and current ongoing medical clinical studies which are registered with the US NIH. These advanced tools include novel delivery systems, personalized medicine diagnostics and therapies based on cannabinoid compounds. Cannabics' research is devoted to the discovery of cannabinoid compounds targeted to specific cancers based on the confluence of cutting edge technologies and personalized bioinformatic markers.

Your Recent History
Gulf Keyst..
FTSE 100
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.